The recall was initiated due to the discovery of N-nitroso-duloxetine, a chemical impurity classified as a nitrosamine.

The Food and Drug Administration (FDA) issued a Class II recall of more than 7,100 bottles of the antidepressant duloxetine ...

Over 7,000 bottles of the antidepressant medication duloxetine, sold under the brand name Cymbalta, have been recalled, the ...

The FDA is recalling more than 7,000 bottles of the antidepressant duloxetine due to a possible cancer-causing chemical.

Antidepressants, the gold standard treatment for depression, don’t work for many people. Will psilocybin be an alternative?

New survey data from New Ocean Health finds nearly three-quarters of its respondents have been diagnosed with at least one chronic condition affecting their physical and mental health. The most common ...

QHSLab, Inc. (the "Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based healthcare solutions, is pleased to ...

Staff Writer Sophia Robertson acknowledges the prevalence of seasonal depression in the approaching winter months and offers ...

Although most research and attention focus on adults, children and adolescents suffer from chronic pain and mental health disorders in numbers as high as adults.

It is not an evidence-based treatment and is opposed by all major medical organizations. In fact, research continues to support that conversion therapy is harmful, especially for LGBTQ youth. In 2007, ...

Undergoing medical tattooing can be considered the “end” of the breast cancer journey. While they may need continued follow-up with their oncologist, by addressing the physical appearance of their ...

Cybin is a promising value investment, with advanced clinical trials and strong institutional support, poised to disrupt ...